2020
DOI: 10.1101/2020.02.27.968297
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

RNA-protein interaction mapping via MS2 or Cas13-based APEX targeting

Abstract: RNA-protein interactions underlie a wide range of cellular processes. Improved methods are needed to systematically map RNA-protein interactions in living cells in an unbiased manner. Capitalizing on the ability of the engineered peroxidase APEX2 to identify protein interaction partners via proximity-dependent biotinylation, we used two approaches to target APEX2 to specific cellular RNAs. Both an MS2-MCP system and an engineered CRISPR-Cas13 system were able to deliver APEX2 to the human telomerase RNA hTR wi… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(24 citation statements)
references
References 88 publications
0
24
0
Order By: Relevance
“…Further, their modular nature enables the facile fusion of effector domains to expand effector functionality. As a result, a broad suite of Cas13-based tools is now able to perturb RNA expression (Abudayyeh et al, 2017; Konermann et al, 2018) or splicing (Konermann et al, 2018), mediate RNA editing (Abudayyeh et al, 2019; Cox et al, 2017; Xu et al, 2021) or methylation (Wilson et al, 2020), as well as profile RNA-protein interactions (Han et al, 2020). These capabilities are now accelerating applications across the study of fundamental RNA biology, RNA-based therapeutics, and molecular diagnostics.…”
Section: Introductionmentioning
confidence: 99%
“…Further, their modular nature enables the facile fusion of effector domains to expand effector functionality. As a result, a broad suite of Cas13-based tools is now able to perturb RNA expression (Abudayyeh et al, 2017; Konermann et al, 2018) or splicing (Konermann et al, 2018), mediate RNA editing (Abudayyeh et al, 2019; Cox et al, 2017; Xu et al, 2021) or methylation (Wilson et al, 2020), as well as profile RNA-protein interactions (Han et al, 2020). These capabilities are now accelerating applications across the study of fundamental RNA biology, RNA-based therapeutics, and molecular diagnostics.…”
Section: Introductionmentioning
confidence: 99%
“…Especially when combined with functional assays and screens, split-TurboID-based PL can be a powerful tool for biological discovery around organelle contact sites or macromolecular complexes. Split-TurboID may also improve signal-tonoise for challenging targeting applications, such as dCas9-directed PL of specific genomic loci (49,50), or dCas13-directed PL of specific cellular RNAs (51).…”
Section: Discussionmentioning
confidence: 99%
“…Cas13, a type Ⅳ CRISPR/Cas system protein, assembles with crispr RNA (crRNA) and forms a crRNA-guided RNA targeting effector complex to directly cut RNA (157). Similarly, catalytically dead RCas9 (dRCas9) and Cas13 (dCas13) have been used as RNA-targeting tools to image RNA and to identify interaction proteins of RNA (158,159). Recently, combining with m 6 A writers or erasers, these two systems are successfully applied into programming RNA modification (Fig.…”
Section: Programmable M 6 a Editing Based On M 6 A Writers/erasers-conjugated Crispr/cas Systemmentioning
confidence: 99%